Abstract
Apathy is an uncertain nosographical entity, which includes reduced motivation, abulia, decreased empathy, and lack of emotional involvement; it is an important and heavy-burden clinical condition which strongly impacts in everyday life events, affects the common daily living abilities, reduced the inner goal directed behavior, and gives the heaviest burden on caregivers. Is a quite common comorbidity of many neurological disease, However, there is no definite consensus on the role of apathy in clinical practice, no definite data on anatomical circuits involved in its development, and no definite instrument to detect it at bedside. As a general observation, the occurrence of apathy is connected to damage of prefrontal cortex (PFC) and basal ganglia; “emotional affective” apathy may be related to the orbitomedial PFC and ventral striatum; “cognitive apathy” may be associated with dysfunction of lateral PFC and dorsal caudate nuclei; deficit of “autoactivation” may be due to bilateral lesions of the internal portion of globus pallidus, bilateral paramedian thalamic lesions, or the dorsomedial portion of PFC. On the other hand, apathy severity has been connected to neurofibrillary tangles density in the anterior cingulate gyrus and to gray matter atrophy in the anterior cingulate (ACC) and in the left medial frontal cortex, confirmed by functional imaging studies. These neural networks are linked to projects, judjing and planning, execution and selection common actions, and through the basolateral amygdala and nucleus accumbens projects to the frontostriatal and to the dorsolateral prefrontal cortex. Therefore, an alteration of these circuitry caused a lack of insight, a reduction of decision-making strategies, and a reduced speedness in action decision, major responsible for apathy. Emergent role concerns also the parietal cortex, with its direct action motivation control. We will discuss the importance of these circuits in different pathologies, degenerative or vascular, acute or chronic.
Introduction
The clinical importance of apathy is more and more amplified in neuro-pathological context, especially and at the moment, related specifically to frontal-subcortical circuit alteration (Starkstein et al., 1992; Duffy, 2000; Aarsland et al., 2001; Starkstein and Leentjens, 2008; Massimo et al., 2009; Chase, 2011; Moretti et al., 2012). The overt definition of apathy is that of a reduced motivation, which directly involve the goal-directed behavior (Duffy, 2000) with a diminishment of emotional involvement, and difficulty in the beginning of new actions (Duffy, 2000).
Apathy is a widespread condition, in many neurological pathology, whose recognition might be helpful for dedicated therapy (Hoehn-Saric et al., 1990; McConnell et al., 1996; Campbell and Duffy, 1997; Castellon et al., 1998; Kant et al., 1998; Diaz-Olavarrieta et al., 1999; Okada et al., 1999; Cummings, 2000).
If not entirely accepted, there are many different categorization of apathy; one of the most anatomical and patho-physiological is the one, proposed (Duffy, 2000) in which different anatomical networks are involved: therefore, Duffy (2000) proposed the terms of cognitive apathy, as the one caused by an alteration of the dorso-frontal cortex, and which brings to dyseexecutive alteration; of motor apathy (Duffy, 2000) with an alteration of motor speedness and execution, mainly related to the extra-pyramidal disrupted circuits(Duffy, 2000); of cortical-sensory apathy (Duffy, 2000), due to altered teleceptive process, and therefore causing the inability to motivate and act as a consequence of sensory stimuli; and of emotional apathy(Duffy, 2000), due to an incapacity to employ the inner planning and voluntary stimulus to act with a defined aim, for a disorder of the extended region of the amygdala (Marin, 1997a,b; Duffy, 2000).
Robert et al. (2009) proposed novel diagnostic criteria for apathy which have been most widely used in recent studies. These can be summarized as lack of motivation associated with lack of:
Goal-directed behavior;
Goal-directed cognitive activity;
Spontaneous or reactive emotional expression, frequently characterized as “emotional blunting.”
In more recent days, Quaranta et al. (2012) connected the occurrence of apathy to damage of prefrontal cortex (PFC) and basal ganglia (Chase, 2011), and define it as:
Emotional apathy (associated with damages of ventral striatum and orbitomedial PFC behavior form of FTD bvFTD; Quaranta et al., 2012);
Cognitive apathy (correlated with an impairment of the lateral PFC and dorsal caudate nuclei; Quaranta et al., 2012);
Deficit of auto-activation (Quaranta et al., 2012; derived from the bilateral lesions of the dorsomedial portion of PFC, the internal portion of globus pallidus, or bilateral paramedian thalamic lesions; Marin et al., 1991; Marin, 1996; Levy and Dubois, 2006; Peters et al., 2006; Zamboni et al., 2008; Chow et al., 2009; Moll et al., 2011).
As far as we have above reported, there are many different possible systematic categorization for apathy, but, at the moment, there is not an adequate and world- accepted gold-standard scale to measure apathy; in particular, there are many shortcomings of the different existing scale, due to the fact that some are heavily standing on caregivers, some other consider apathy in the context of different other neuropsychiatric events (Loewenstein et al., 2001; Njomboro and Deb, 2012; Cummings et al., 2015a,b). What it is strongly recommended is that the clinician should evaluate apathy inside the clinical behavior and cognitive status of the patient, and even in his environment situation (Duffy, 2000).
What do we know from animal experiments and single case studies
The frontal-subcortical circuitry provides a unifying framework for understanding apathy (Alexander, 1994; Litvan, 2001; Monchi et al., 2006; Bonelli and Cummings, 2007).
Alexander et al. (Alexander et al., 1986, 1990; Alexander and Crutcher, 1990; Alexander, 1994) proposed that the basal ganglia and thalamus are intimately related to frontal cortex and the inside of subcortical-frontal networks, in five parallel circuits (Alexander et al., 1986, 1990; Alexander and Crutcher, 1990; Alexander, 1994). Two of these circuits influence the skeletal motor executive function and the ocular-motor areas.
The other three loops connect the basal ganglia and thalamus to the dorsolateral prefrontal cortex the lateral orbitofrontal cortex and the anterior cingulate/medial orbitofrontal areas (Alexander et al., 1986, 1990; Alexander and Crutcher, 1990; Alexander, 1994). The areas are involved in executive functions, attention, working-memory, focusing attention, and judgment (Fielding et al., 2006; Bonelli and Cummings, 2008). PET and fMRI imaging publications confirmed in vivo these models (Postuma and Dagher, 2006; Bonelli and Cummings, 2007).
The topical organization of the prefrontal cortex network is strongly reflected in the dynamic development of prefrontostriatal regions of connections (Yeterian and Van Hoesen, 1978; Yeterian and Pandya, 1991; Flaherty and Graybiel, 1993; Lattery et al., 2001; Bonelli and Cummings, 2007). The striatum recombined the information derived from the cortex to form small and specialized areas (Divac et al., 1967; Johnson et al., 1968; Divac, 1972; Brown, 1992; Lichter and Cummings, 2001; Hirata et al., 2006).
The two motor circuits (Lehericy et al., 2006) send impulses directly toward the putamen, then to ventrolateral globus pallidus internal (GPi), globus pallidus external (GPe), and caudolateral SN. The globus pallidus (GP) connects to the ventrolateral, ventral anterior, and centromedianum nuclei of the thalamus, which send projections directly to the supplementary motor area, premotor cortex, and motor cortex, completing this way the circuit.
There are three other circuits, which starts from BG and arrives to frontal areas, which are behaviorally relevant:
A dorsolateral-prefrontal circuit, which seems involved in executive functions (Alexander and Crutcher, 1990; Alexander et al., 1990; Alexander, 1994);
An anterior cingulate circuit, involved in motivational mechanisms (Alexander and Crutcher, 1990; Alexander et al., 1990; Alexander, 1994);
An orbitofrontal circuit, with lateral and medial sections. The medial part permits integration of visceral-amygdalar functions with the internal state of the organism; the lateral portion is involved with transformation of limbic and emotional information into contextually appropriate behavioral responses (Alexander and Crutcher, 1990; Alexander et al., 1990; Alexander, 1994).
Each circuit has two pathways:
Direct pathway, featuring a monosynaptic link between the GPi-SN pars reticulata (SNr) complex;
Indirect pathway, projects from striatum to GPe, connecting to the Gpi-SNr complex via the subthalamic nucleus (STN; Alexander and Crutcher, 1990; Alexander et al., 1990).
Both direct and indirect circuits project to the thalamus.
Although, each frontal-subcortical circuit constitutes a closed loop of anatomically segregated dedicated neurons, “open”-loop elements are incorporated into their functional connectivity, including parietal cortex, thalamic nuclei, prestriate cortex, and amygdala nuclei (Groenewegen and Berendse, 1990; Parent, 1990; Weinberger, 1993; Salmon et al., 2001; Bonelli et al., 2006; Bonelli and Cummings, 2007).
The dorsolateral prefrontal circuit begins in the cortical regions of areas 9 and 10, projects to the caudate nucleus (Selemon and Goldman-Rakic, 1985), via the direct pathways to the lateral faces of the GPi and SNr (Parent et al., 1984). The indirect pathway project to the dorsal GPe, and subsequently to the lateral STN (Smith and Bolam, 1990). Neurons from the lateral STN send afferents to the GPi-SNr complex. The output efferents from the basal ganglia project directly to the mediodorsal and ventral anterior thalamus (Kim et al., 1976; Illinsky et al., 1985), and return to Brodmann's areas 9 and 10 (Kievit and Kuypers, 1977; Giguere and Goldman-Rakic, 1988), relating these circuits to executive function. The prefrontal cortex can be considered as the most developed cortical site for the control and the correct operative selection of executive functions and appropriate behavior (Kolb et al., 2004; Nácher et al., 2006; Alexander and Brown, 2011). As pointed out by Leal-Campanario et al. (2013) it seems more precise to better define the prefrontal cortex into the dorsolateral part, which seems to be tightly bound to the working memory and to the correct operative choice of appropriate behavior, and the medial prefrontal area, which appears to guarantee the emotional color of intentional action and of the acquired act, including for animals and humans, as perfectly stated by Leal-Campanario et al. (2013) “associative conditioning” (Weiss and Disterhoft, 2011; Jurado-Parras et al., 2012). Studies based on transcranial magnetic stimulation support the hypothesized role of the prefrontal cortex (Petrosini, 2007) and experimental data extend it toward its projection on nucleus accumbens (Jurado-Parras et al., 2012) in imitative learning in humans. To become even more precise, the caudal medial prefrontal part participate in the gaining, and in the recovery of the conditioning (Simon et al., 2005), whereas the rostral medial part restrains the conditioned act sequence, without limiting its acquisition (Leal-Campanario et al., 2007, 2013). To the rostral part of the medial dorsal prefrontal cortex widely projects the mediodorsal thalamic nucleus (Leal-Campanario et al., 2007, 2013) and diffuse projections from it and arrives to the anterior cingulate cortex (ACC), exerting on it an inhibitory effect, but also suggesting that the effects of this area is not constant and univocal, but it acts as an ongoing control system, decreasing or increasing the operative execution of a conditioned response, in relation to environment, time, and occurrence. In fact, what clearly merge from another important study (the rostral medial prefrontal cortex inhibits the execution of the reflexed motor act, evoking what Leal-Campanario et al., 2007) defined as “a freezing behavior,” but rather curiously, this marked inhibition to-act system does not reduce the possibility to acquire different conditioned response. On the contrary, when there is a cortical depression of this area, the animal can act more rapidly in response to a condition stimulus (Weiss and Disterhoft, 2011; Leal-Campanario et al., 2013).
This ongoing control process is exerted directly from the discharge of the rostral medial part of prefrontal cortex, but highly supported by its diffuse projections to caudate, and claustrum and via these nuclei to the basal ganglia, mediodorsal thalamic nuclei, as above mentioned, and to midline thalamic nuclei, highly related to the process of arousal, selective attention, but also to the substantia nigra pars reticulate, fundamental for motor action incipit (Basso and Evinger, 1996; Kronforst-Collins and Disterhoft, 1998; Siegel et al., 2012; Leal-Campanario et al., 2013), to the superior colliculus and to pontine nuclei (Kronforst-Collins and Disterhoft, 1998; Fuster, 2001; Siegel et al., 2012).
The orbitofrontal circuit begins in the lateral orbital gyrus of area 11 (Mega and Cohenour, 1997; Mega et al., 1997) and in the medial inferior frontal gyrus of the areas 10 and 47 in humans (Mega and Cohenour, 1997; Mega et al., 1997), send projections to caudate, then to the SNr and to GPi (Johnson and Rosvold, 1971). The caudate is the start point of an indirect loop (Smith et al., 1990), which passes through the dorsal GPe, the STN side, and reaches GPi and SNr (Smith et al., 1990). Neural networks from the GP and SN to the mediodorsal thalamus and ventral anterior thalamus (Illinsky et al., 1985; Selemon and Goldman-Rakic, 1985) complete the neural loop into the lateral orbitofrontal cortex (Illinsky et al., 1985).
There is another division of this circuit that has been identified by various studies (Mega and Cohenour, 1997; Mega et al., 1997): the fibers originate from inferomedial prefrontal cortex, and the medial orbital gyrus of area 11 (Mega and Cohenour, 1997; Mega et al., 1997) and project to the accumbens, to medio-ventral pallidum; they arrive into the mediodorsal thalamic nucleus, and to conclude the loop arrive in the medial orbitofrontal cortex (Mega and Cohenour, 1997; Mega et al., 1997). This portion of the cortex has reciprocal relations with the magnocellular division of the accessory basal amygdala (Mega and Cohenour, 1997; Mega et al., 1997). The orbitofrontal inferomedial cortex has many other ways of connecting with the rostral insula, and Brodmann's areas 24, 25, 32 (infracallosal cingulate areas), and 38, regions that are part of the ACC (Johnson and Rosvold, 1971; Mega and Cohenour, 1997; Mega et al., 1997). The orbitofrontal cortex receives inputs from the limbic system (Lichter and Cummings, 2001) and participate in the awareness, in the insight, in the appropriate, and predefinite social conduct (Eslinger and Damasio, 1985; Starkstein and Kremer, 2001). In fact, ACC is the trait d'union between area 24 and the ventromedial caudate, putamen, nucleus accumbens, and olfactory tubercle (Selemon and Goldman-Rakic, 1985), originally defined as the limbic striatum (Levy and Dubois, 2006); from these nuclei the fibers arrives to the GPi and GPe(Lichter and Cummings, 2001) and to SN (Critchley, 2005). Now, the connection system, at this point, departs from GPe and arrives to STN, which directs to the ventral pallidum (Leal-Campanario et al., 2013), from that point via the mediodorsal thalamus (Critchley, 2005) and conclude the loop into the anterior ACC (Goldman-Rakic and Porrino, 1985).
Two clinical conditions have been related to lesions in these regions.
The first one is the “Akinetic mutism,” clinically related to a lesion of the anterior cingulate, either unilaterally, either bilaterally (Ackermann and Ziegler, 1995; Mega and Cohenour, 1997; Mega et al., 1997; Oberndorfer et al., 2002). Akinetic mutism is a dramatic clinical condition where the human being is apathic, totally deprived of motivation, absent of primary stimuli, such as hunger, psycho-motor initiative, lack of verbalization, and inability to answer questions or commands (Goldman-Rakic and Porrino, 1985; Ackermann and Ziegler, 1995; Mega and Cohenour, 1997; Mega et al., 1997; Oomman and Madhusudhanan, 1999; Anderson et al., 2003; Tengvar et al., 2004).
The second one is apathy, driven out by bilateral lesions of ventrolateral and dorsomedial thalamic nuclei (Bogousslavsky et al., 1988; Levy and Dubois, 2006), GP and the internal capsule (Helgason et al., 1988; Starkstein et al., 1993), the ansa lenticularis (internal pallidal, posterior limb of the internal capsule, and end in the peduncolopontine nucleus; Bechara and van der Kooy, 1989; Bhatia and Marsden, 1994; Ackermann and Ziegler, 1995). We can induce a syndrome similar to akinetic mutism injecting 6-hydroxy dopamine in the SN, ventral tegmental area, or nigrostriatal tract within the medial forebrain bundles of the lateral hypothalamus (Ungerstedt, 1970, 1971). Administration of apomorphine (a direct dopamine agonist) could reverse behavioral deficits (Ungerstedt, 1971; Marshall and Ungerstedt, 1976) and a pretreatment with spiroperidol (a dopamine receptor antagonist), could block them (Marshall and Gotthelf, 1979).
Confirmation of these observations came from the case of a patient who developed akinetic mutism due to surgical removal of a tumor of the anterior hypothalamus who responded to treatment with lergotrile and bromocriptine (dopamine receptor agonists), but not to carbidopa/L -dopa or methylphenidate (presynaptic dopamine mimetics; Ross and Stewart, 1981). This case suggested that the base of akinesia and apathy lies on a direct loss of dopaminergic input to the cingulate or other corticolimbic structures rather than to the striatum (Nemeth et al., 1986; Echiverri et al., 1988; Combarros et al., 2000; Alexander, 2001).
As with akinetic mutism, even for apathy, it was observed a substantial response to treatment with dopamine-agonists, suggesting a common role of dopaminergic pathways in both conditions (Marin et al., 1995; Watanabe et al., 1995; Lichter and Cummings, 2001). Apathy that appears in experimental models of Alzheimer's disease can be also interpreted as an alteration of cholinergic disconnections of structures of the ACC, e.g., basal nucleus of the amygdala (Mega and Cohenour, 1997; Mega et al., 1997), and the paramedian thalamic portions, probably for their intrinsic role of connecting basal forebrain to the ARAS system, deriving from the cholinergic pedunculo-pontine projections.
To summarize, we can detect a theoretical model for the Neural Substrates of Motivation traced out by Kalivas: (Kalivas et al., 1994)
Subcircuit number 1 (Kalivas et al., 1994): this circuit is mediated by a loop via the ventral tegmentum, through the nucleus accumbens and to the ventral pallidum. As Kalivas pointed out, this circuit gives motivation to the operative process, in the “motivational working memory” (Kalivas et al., 1994).
Subcircuit number 2 (Kalivas et al., 1994): this circuit is composed by the ventral pallidum, the medial dorsal nucleus of the thalamus, the prefrontal cortex, the nucleus accumbens, and the ventral tegmentum. As Kalivas (Kalivas et al., 1994) underlined this network provides “the cognitive coloring of motivation” (Kalivas et al., 1994).
Subcircuit number 3 (Kalivas et al., 1994): this circuit is composed by the projections via the ventral pallidum, the pedunculo-pontine nucleus and the ventral tegmentum, and strengths the passage from the arousal into motivation (Kalivas et al., 1994).
Subcircuit number 4 (Kalivas et al., 1994): this circuit occurs between the ventral tegmentum and nucleus accumbens, via the amygdala and implements the “reward memory into motivational response” (Kalivas et al., 1994).
Dopamine is the principal neurotransmitter of the four dopaminergic systems; nigro-striatal, mescortical, meso-limbic, and tubero-infundibular vias. Dopamine subserves various system, in particular concerning the arousal, the motor refinement system, the goal-motivation (Duffy, 1997a,b, 2000).
The cholinergic network is a widespread system, which originates form the Meynert nucleus, participate to the ARAS system, which arrives to the mesencephalic and tectal region, the limbic system, regulates the extrapyramidal nigro-striatal dopaminergic system, the thalamic nuclei, and basal forebrain. Therefore, cholinesterase and butyrrilcholinesterase inhibitors have been employed for apathy therapy (Hoehn-Saric et al., 1990; Duffy, 2000).
Serotonin, a part from the mood and pain modulation regulatory system, via raphe magnum and frontal projections, has an intrinsic activity on enhancing the dopamine networks of the ventral tegmentum and nucleus accumbens (Duffy, 2000) via the 5-HT3 receptors, reinforcing therefore motivational tenor (Kalivas et al., 1994; Duffy, 2000) (Supplementary Material).
What do we know about apathy from clinical practice?
Apathy is common in distinct neurological disorders. There are no authoritative estimates available on the prevalence of apathy in general, but it has been estimated that ~10 million people in the US suffer from apathy (Chase, 2011; Clarke et al., 2011; van Dalen et al., 2013). Across various disorders, apathy is regarded as the strongest predictor of poor cognitive, functional, and occupational outcome, reduced medication compliance, increased caregiver burden, diminished quality of life, and general health (Levy et al., 1998; Stuss et al., 2000; van Reekum et al., 2005; Guimaraes et al., 2008; Dujardin et al., 2009; Ishii et al., 2009; Starkstein et al., 2009; Jorge et al., 2010; Benoit and Robert, 2011; Chase, 2011; Clarke et al., 2011; Kostic and Filippi, 2011; Hsieh et al., 2012; Caeiro et al., 2013; Moretti et al., 2013; Santangelo et al., 2013; van Dalen et al., 2013; Stella et al., 2014; Theleritis et al., 2014; Fervaha et al., 2015; McIntosh et al., 2015).
Apathy following cerebrovascular accidents
Many data seem to forewarn the clinician that a patient with CVS may develop an apathy syndrome (which has been defined as a Post-Stroke-Apathy, PSA; Brown and Pluck, 2000). Tatemichi et al. (1992) postulate that stroke lesions to the posterior limbs of internal capsule disrupt the major outflow tract of the internal pallidum, the ansa lenticularis, which connects to the mesencephalic locomotor region (MLR), critical in generating goal-oriented behavior (Tatemichi et al., 1992; Kos et al., 2016). Okada et al. (1997) reported that apathy is related to reduced cerebral blood flow in the right dorsolateral frontal and left frontotemporal regions (Duffy, 2000; Hama et al., 2007).
Stroke patients with apathy showed more right-sided lesions in general, and specifically more white- matter hyperintensities within the right fronto-subcortical circuit (Okada et al., 1997; Brodaty et al., 2005; Caeiro et al., 2012), to higher amount of perventricular white matter hyperintensities (Finset and Andersson, 2000), lower fractional anisotropy values (FA) in the anterior corona radiata and right inferior frontal gyrus (Tang et al., 2013), and an increased number of microbleeds (Yang et al., 2015). In a DTI connectivity analysis in stroke patients by Yang et al. (2015) an “apathy-related sub-network” merged in relation with apathy: the right supra-marginal gyrus, right precuneus, and right paracentral lobule, the right superior temporal gyrus, bilateral insula (Yang et al., 2015), the hippocampus, right putamen, right thalamus, and posterior cingulum (Yang et al., 2015).
Within a study focusing apathy due to subcortical lesions, regional changes at a distal location from the lesion site were reported, namely in the posterior cingulate cortex (Tatemichi et al., 1992; Deguchi et al., 2013; Matsuoka et al., 2015), bilateral basal ganglia damage (Levy et al., 1998; Moretti et al., 2013), isolated pontine or cerebellar infarcts (Piamarta et al., 2004; Hoffmann and Cases, 2008; Onoda et al., 2011).
Alzheimer's disease
Alzheimer's disease (AD) affects memory and cognition, but all AD patients develop neuropsychiatric symptoms (NPS; Lyketsos et al., 2000, 2002; Steinberg et al., 2008; Onoda and Yamaguchi, 2011), including apathy (Marin et al., 1991; Robert et al., 2009). NPS is the most important cause of increase of caregiver'stress, but there is no general concordance or FDA-approved medications for NPS in AD (Sultzer et al., 2008; Rosenberg et al., 2013; Porsteinsson et al., 2014; Peters et al., 2015).
An important study by Benoit et al. (1999) demonstrated that apathy but not depressed patients had significantly lower scores on cognitive tests (Porsteinsson et al., 2014).
Ample epidemiological data indicate, on the other hand, that in AD, individual NPS rarely occur alone (Hoffmann and Cases, 2008). While, these groupings have been supported by limited studies (Jonsson et al., 2010; Geda et al., 2013) others do not support this approach (Jeste and Finkel, 2000; Olin et al., 2002; Robert et al., 2009; Trzepacz et al., 2013; Cummings et al., 2015a,b). Data, therefore, might be confused and not unequivocal at all. Many data established a possible link between apathy and AD with a decreased reliability of ACC network, mainly due to an increased generalized amyloid depositions (Canevelli et al., 2013), a volume loss in ACC (Apostolova et al., 2007; Bruen et al., 2008; Marshall et al., 2013; Stanton et al., 2013), a decreased perfusion in ACC (Benoit et al., 2004; Lanctôt et al., 2007; Tunnard et al., 2011), a decreased ACC white matter related integrity (Robert et al., 2006; Kim et al., 2011; Hahn et al., 2013), and increased amyloid burden in right ACC (Ota et al., 2012; Mori et al., 2014). Apathy is also associated with decreased posterior cingulate (PCC metabolism; Migneco et al., 2001), with a reduced insular volume (Moon et al., 2014a; Delrieu et al., 2015), and with decreased inferior temporal cortical (ITC) thickness (Moon et al., 2014b; Guercio et al., 2015), with cortical shrinkage of the frontal cortex (Apostolova et al., 2007; Bruen et al., 2008; Marshall et al., 2013; Stanton et al., 2013), with greater amyloid burden in bilateral frontal cortex (Ota et al., 2012), reduced orbitofrontal metabolism on the left (Donovan et al., 2014) or right (Benoit et al., 2004), and reduced connectivity in left-sided functional connectivity, with thalamus and parietal cortex, and amygdala (Holthoff et al., 2005; Kang et al., 2012; Ota et al., 2012; Baggio et al., 2015). Galantamine, as a cholinesterase inhibitor has been linked to a slower decrease of the putamen metabolism (Zhao et al., 2014), based on FDG-PET study (Zhao et al., 2014). One neurochemical study of CSF in apathy-patients suffering from AD (Mega et al., 2005) demonstrated an higher levels of phospho-tau, related to advanced neurdegenerative process (Skogseth et al., 2008).
Using 99 m-Technetium SPECT cerebral blood flow (CBF) abnormalities were found in bilateral frontal regions: negative correlations were found between apathy and orbitofrontal regions (Benoit et al., 2004; Skogseth et al., 2008), right inferior frontal (Jack et al., 2013), and the right and bilateral medial (Jack et al., 2013; Baggio et al., 2015), and dorsolateral regions, right lingual gyrus (Craig et al., 1996; Benoit et al., 2002; Robert et al., 2006), right posterior temporo-parietal area (Schroeter et al., 2011).
Mori et al. (2014) investigated amyloid-B (AB) deposition using ((11)C) Pittsburgh Compound-B (PiB) PET in relation to apathy in AD: elevated levels of AB are seen (Mori et al., 2014) throughout the whole frontal cortex, bilateral insula, and right ACC.
AD patients white matter alterations related to apathy have been investigated (Kostic and Filippi, 2011). Often DTI is used to evaluate white matter integrity, as quantified with fractional anisotropy (FA). In patients with high apathy, lower FA values were found within the left, right, or bilateral anterior and posterior cingulum, the genu, body, and splenium of the corpus callosum (Holthoff et al., 2005; Hahn et al., 2013; Baggio et al., 2015).
Furthermore, diffusion abnormalities in the right thalamus and parietal regions were associated with higher apathy (Mori et al., 2014; Kang et al., 2012). Data are not univocal (Donovan et al., 2014; Delrieu et al., 2015). One fMRI study found alterations in functional limbic-hypothalamic networks in relation to apathy (Tatemichi et al., 1992; Starkstein et al., 1997; Balthazar et al., 2014).
Furthermore, one study that included both AD and Lewy body disease patients, investigated the relationship between apathy and striatal dopamine uptake, using (123)I-FP-CIT SPECT (Aalten et al., 2008): higher apathy was associated with a reduced dopaminergic binding potential in the right putamen (Aalten et al., 2008). On the other hand, another study reported no association with D2/D3 dopamine receptor density (David et al., 2008; Reeves et al., 2009; Cuthbert and Insel, 2013; Grupe and Nitschke, 2013; Rosenberg et al., 2013).
In our opinion, two of the most significant studies which start form the observation that AD patients did not frequently show isolated NPS symptoms, and that overlap networks should be taken into account are below reported.
Rosenberg et al. (2013) hypothesized, that apathy is one of the many different coexistent behavior symptoms in AD, and therefore these symptoms correlate with a dysfunction in several structures such as ACC, orbitofrontal cortex, and insula, as well as amygdala and striatum. As stated by Grupe and Nitschke (2013), apathy might be the behavior response toward the anxiety-provoking situations, which might be very normal and daily living activity, but inducing apprehension in AD patients (Grupe and Nitschke, 2013). Therefore, in AD one can observe an altered balance mechanism, which alterantively regulates apathy or anxiety.
Parkinson's disease
The very first study on apathy and neurodegenerative pathology concerns Parkinson's Disease (PD): Starkstein et al. (1992) reported that in PD patients apathy is a serious problem, related to greater cognitive impairment, and to depletion of catecholamines in the locus ceruleus. Another clinical study reported that apathy tended to cluster with anxiety, whereas hallucinations, delusions, and irritability formed another distinct behavioral cluster (Insel et al., 2010). There are not adequate existamated prevalence of apathy in PD, arising up to 51% of the entire PD population (Duffy, 2000; Stuss et al., 2000; Starkstein et al., 2009), depending on the assessment and also deriving form not universally considered inclusion/exclusion criteria (Levy et al., 1998; Stuss et al., 2000; Starkstein and Leentjens, 2008; Starkstein et al., 2009; Moretti et al., 2013; many studies included patients with super-imposition of AD with parkinsonism (Stuss et al., 2000; Starkstein and Leentjens, 2008; Dujardin et al., 2009; Starkstein et al., 2009). Starting from the anatomical consideration of dopaminergic pathways, all the four dopaminergic mainstreams, the nigro-striatal, the meso-limbic, the meso-cortical, and the tubero-infundibular dopaminerg can somehow been involved in apathy determination in PD patients (Ljungberg and Ungerstedt, 1976; Insel et al., 2010; Cuthbert and Insel, 2013). But apathy in PD does not seem dependent on the duration of the disease, the severity of symptoms and the dosage of Levodopa; everything indicates that the brain changes that lead to apathy in Parkinson's disease are different from those involved in the apathy associated with motor symptoms (Levy et al., 1998; Dujardin et al., 2009; Moretti et al., 2013). Apathy and depression are quite divided symptoms, with a prevalence of depression than apathy in progressive supranuclear palsy (Insel et al., 2010; Cuthbert and Insel, 2013) of apathy in corticobasal degeneration (Levy et al., 1998; Litvan et al., 1998; Aarsland et al., 1999; Moretti et al., 2013).
Considering the specific information deriving from neuroimaging, apathy in PD has been studied (Tatemichi et al., 1992).
Reijnders et al. (2010) found an association between higher apathy and lower gray matter density values with voxel based morphometry analyses, in the bilateral inferior parietal gyrus, and right precuneus (Reijnders et al., 2010). Skidmore et al. (2013) investigated functional integrity of the brain in relation to apathy by using voxel-wise fractional amplitude of low frequency fluctuations analysis in resting state fMRI data: apathy was best predicted by a lower signal amplitude in the right middle orbitofrontal cortex and bilateral subgenual cingulate cortex, in the left supplementary motor cortex (SMA), the left inferior parietal lobule, and left fusiforme gyrus (Robert et al., 2012; Skidmore et al., 2013). According to the review by Kos et al. (2016) multiple fluorodeoxyglucose (FDG-) PET-studies specifically found a positive correlation of apathy and cerebral metabolism during rest in the right middle frontal gyrus, right inferior frontal gyrus, left anterior insula (Skidmore et al., 2013), bilateral orbitofrontal lobes, and bilateral anterior cingulate (Robert et al., 2012), and left posterior cingulate cortex (Huang et al., 2013), an increased cerebral metabolism in the right cuneus (Skidmore et al., 2013) and reduced metabolism within the right inferior parietal lobe and left superior temporal gyrus (Robert et al., 2012). Functional connectivity within the striatum and between striatal and ventrolateral prefrontal regions was more impaired in patients with high apathy compared to low (Holthoff et al., 2005). Data are not univocal, since two other studies (Robert et al., 2009, 2014) did not find out any structural differences when comparing apathetic to non-apathetic PD patients.
As strongly pointed out by Kos et al. (2016), it has been found an inverse correlation between catecholaminergic binding potential, indicative of a specific loss of dopamine and noradrenaline innervation and apathy, in the bilateral ventral striatum in resting-state analysis (Isella et al., 2002).
Subcortical vascular dementia
Subcortical vascular dementia (sVaD) relates to small-vessel disease (Remy et al., 2005) and encompasses small vessel arteriosclerosis, liphyalinosis and arteriosclerosis (Remy et al., 2005), resulting in lacunar infarct occurring in distribution of small arterioles, usually in the white matter, basal ganglia, thalamus, and pons (Roman et al., 1993; Remy et al., 2005; Jelinger, 2013). Due to the anatomical disposition, sVAD include a systemic progressive dysexecutive syndrome, and apathy (Chui, 2001; Dujardin et al., 2009; Moretti et al., 2015). Starkstein et al. (2009) observed that in patients who experienced apathy in combination with depression, more white matter hyperintensities were found in the parietal lobes compared to patients without apathy and depression or in groups with apathy or depression only [see data and comments in Kos et al. (2016)]. Neuropathological data here lacks, but can be resumed from other studies.
Guimaraes et al. (2008) adapted a pathophysiological model for apathy in AD, for sVAD: ACC and OFC (involved in goal—motivated planned action) via the basolateral amygdala and nucleus accumbens, projects to the ascending frontostriatal pathway and to the dorsolateral prefrontal cortex (PFC), fundamental for the executing correct behavior (Guimaraes et al., 2008). Damage to the ACC and OFC leads to apathy (Guimaraes et al., 2008): the same result might be derived from the damage of the connecting subcortical vias, from BG to ACC and OFC (Guimaraes et al., 2008). In our opinion (Chui, 2001; Dujardin et al., 2009), we suggest a putative role for the subcortical networks in connection with the pars triangularis, the superior frontal gyrus, and the orbital operculum and may suggest that degeneration of the neural networks toward OFC and ACC can be associated to apathy, as the same result, via different pathway (Chui, 2001; Dujardin et al., 2009). Recently, white matter hyperintensities in the frontal cortical and subcortical areas have been associated with apathy (McIntosh et al., 2015), not confirmed by another study (Pluck and Brown, 2002). Behavior alterations and white-matter lacunes of basal ganglia in AD resulted in a two- to three-fold increased risk of delusions, apathy, hallucinations, and depression (Rosen et al., 2005).
Even if there are very few, and limited cases of sVAD neuroimaging dedicated study for the correlation between apathy and white matter burden, we can deduct some information in the AD patients with white matter alterations and apathy (Kos et al., 2016). In patients with high apathy, lower FA values were found within the left, right, or bilateral anterior and posterior cingulum (Ott et al., 1996; Robert et al., 2006; Kang et al., 2012; Hahn et al., 2013), with non-specific white matter changes (Tighe et al., 2012; Geda et al., 2013) and with additional increment of white matter hyper- intensities in the frontal lobes (Starkstein et al., 2009) and basal ganglia (Baggio et al., 2015), of the right thalamus and parietal regions (Kang et al., 2012). New dedicated studies should take sVAD and apathy as the principal focus of neuroimaging detection.
Conclusive statement
Apathy is a widespread condition, which definitively increment the burden of the basal predisposing neurological conditions; there are, at the moment, not adequate clinical instrument, to evaluate it.
What do we know form animal models (Watanabe et al., 1995) is that apathy should be subserved by four different circuits, which mediates the motivational working memory, the cognitive coloring of motivation, the integration of arousal into motivation, and the reward memory into motivational response.
The information which derived from in vivo clinical practice do not object and refuse these circuits.
Kos et al. (2016) and Tatemichi et al. (1992) review confirms the association between abnormalities within the fronto-subcortical circuitry and apathy. In addition, this review highlights the involvement of the ACC and adds the inferior parietal cortex as a region of interest (Kos et al., 2016; Guimaraes et al., 2008; Chui, 2001; Moretti et al., 2015), relating ACC and parietal cortex in motivation and reward systems (Tekin and Cummings, 2002; Carrera and Bogousslavsky, 2006; Palmqvist et al., 2011; Rochat et al., 2013; Blundo and Gerace, 2015).
Wide neural networks support apathy: the medial frontal regions and the dorsolateral prefrontal cortex (DLPFC), the so-called “executive circuit” supports the ability to generate and maintain purposeful, goal-directed behavior (Dujardin et al., 2009; Quaranta et al., 2012). The inferior parietal cortex, described primarily by Litvan (Aarsland et al., 1999), in cortico-basal degeneration patients, where apathy is much more common than in PSP or PD [data confirmed in Moretti et al. (2005) (Hoffstaedter et al., 2013; Westerholz et al., 2014)], is involved too. By means of fMRI, the inferior parietal cortex (Westerholz et al., 2014) increased activation (among other regions in the fronto-subcortical network) during self-initiated movements and goal-directed behavior in a healthy sample (Jenkins et al., 2000; Desmurget and Sirigu, 2009; Westerholz et al., 2014; Kos et al., 2016).
Impairments in the generation of ideas for possible actions may lead to a lack of goal-directed behavior which can be associated with abnormalities in dorsolateral prefrontal areas, in caudate dorsal nucleus, and anterior thalamic nuclei (Levy and Dubois, 2006). But it has also been suggested that apathy can arise because of an inability to actually start and execute actions, which is related to the auto-activation subtype as proposed by Levy and Dubois (2006). Kos et al. (2016) suggest that this lack of volunty to move and failure to start motor programs may additionally be due to abnormalities within the inferior parietal cortex (Aarsland et al., 1999; Tekin and Cummings, 2002).
More studies should be directed toward goal specific problems;
Create an univocal and well accepted anatomical-pathophysiological integrated model of neural circuits involved in apathy (that should be open and should comprise apathy as a general phenomenon, and not apathy into specific pathologies, such as PD or AD)
Define the operative neuropsychological instruments to define in a clinical operative context apathy, in a strong predictive test, not strongly based on caregiver' referral, not limited to patient opinions, or simply by clinical observation
Dedicate purposed study to detect the strength of this instrument with the integrative support of modern neuroimaging techniques.
Statements
Author contributions
RM and RS design and wrote the manuscript, analyzed the literature, and participated to the final writing and critically drafted the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: http://journal.frontiersin.org/article/10.3389/fnagi.2016.00289/full#supplementary-material
References
1
AaltenP.VerheyF. R.BozikiM.BrugnoloA.BullockR.ByrneE. J.et al. (2008). Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Dement. Geriatr. Cogn. Disord.25, 1–8. 10.1159/000111082
2
AarslandD.LarsenJ. P.LimN. G.JanvinC.KarlsenK.TandbergE.et al. (1999). Range of neuropsychiatric disturbances in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry.67, 492–496. 10.1136/jnnp.67.4.492
3
AarslandD.LitvanI.LarsenJ. P. (2001). Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J. Neuropsychiatry Clin. Neurosci.13, 42–49. 10.1176/jnp.13.1.42
4
AckermannH.ZieglerW. (1995). Akinetischer mutismus-eine literaturübersicht. Fortschr. Neurol. Psychiatr.63, 59–67. 10.1055/s-2007-996603
5
AlexanderG. E. (1994). Basal ganglia-thalamocortical circuits: their role in control of movements. J. Clin. Neurophysiol.11, 420–431. 10.1097/00004691-199407000-00004
6
AlexanderG. E.CrutcherM. D. (1990). Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci.13, 266–271. 10.1016/0166-2236(90)90107-L
7
AlexanderG. E.CrutcherM. D.DeLongM. R. (1990). Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Prog. Brain Res.85, 119–146. 10.1016/S0079-6123(08)62678-3
8
AlexanderG. E.DeLongM. R.StrickP. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci.9, 357–381. 10.1146/annurev.ne.09.030186.002041
9
AlexanderM. P. (2001). Chronic akinetic mutism after mesencephalic-diencephalic infarction: remediated with dopaminergic medications. Neurorehab. Neural Repair.15, 151–156. 10.1177/154596830101500208
10
AlexanderW. H.BrownJ. W. (2011). Medial prefrontal cortex as an action-outcome predictor. Nat. Neurosci.14, 1338–1344. 10.1038/nn.2921
11
AndersonC. A.ArciniegasD. B.HuddleD. C.LeeheyM. A. (2003). Akinetic mutism following unilateral anterior cerebral artery occlusion. J. Neuropsychiatry Clin. Neurosci.15, 385–386. 10.1176/jnp.15.3.385
12
ApostolovaL. G.AkopyanG. G.PartialiN.SteinerC. A.DuttonR. A.HayashiK. M.et al. (2007). Structural correlates of apathy in Alzheimer's disease. Dement. Geriatr. Cogn. Disord.24, 91– 97. 10.1159/000103914
13
BaggioH. C.SeguraB.Garrido-MillanJ. L.MartiM. J.ComptaY.ValldeoriolaF.et al. (2015). Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathy. Mov. Disord.30, 671–679. 10.1002/mds.26137
14
BalthazarM. L.PereiraF. R.LopesT. M.da SilvaE. L.CoanA. C.CamposB. M.et al. (2014). Neuropsychiatric symptoms in Alzheimer's disease are related to functional connectivity alterations in the salience network. Hum. Brain Mapp.35, 1237–1246. 10.1002/hbm.22248
15
BassoM. A.EvingerC. (1996). An explanation for reflex blink hyperexcitability in Parkinson's disease. II. Nucleus raphe magnus. J. Neurosci.16, 7318–7330.
16
BecharaA.van der KooyD. (1989). The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine. J. Neurosci.9, 3400–3409.
17
BenoitM.ClairetS.KoulibalyP. M.DarcourtJ.RobertP. H. (2004). Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease. Int. J. Geriatr. Psychiatry19, 864–869. 10.1002/gps.1163
18
BenoitM.DygaiI.MignecoO.et al. (1999). Behavioral and psychological symptoms in Alzheimer's disease. Relation between apathy and regional cerebral perfusion. Dement. Geriatr. Cogn. Disord.10, 511–517. 10.1159/000017198
19
BenoitM.KoulibalyP. M.MignecoO.DarcourtJ.PringueyD. J.RobertP. H. (2002). Brain perfusion in Alzheimer's disease with and without apathy: a SPECT study with statistical parametric mapping analysis. Psychiatry Res.114, 103–111. 10.1016/S0925-4927(02)00003-3
20
BenoitM.RobertP. H. (2011). Imaging correlates of apathy and depression in Parkinson's disease. J. Neurol. Sci.310, 58–60. 10.1016/j.jns.2011.07.006
21
BhatiaK. P.MarsdenC. D. (1994). The behavioral and motor consequences of focal lesions of the basal ganglia in man. Brain117, 859–876. 10.1093/brain/117.4.859
22
BlundoC.GeraceC. (2015). Dopamine agonists can improve pure apathy associated with lesions of the prefrontal-basal ganglia functional system. Neurol. Sci.36, 1197–1201. 10.1007/s10072-014-2061-5
23
BogousslavskyJ.FerrazziniM.RegliF.AssalG.TanabeH.Delaloye-BischofA. (1988). Manic delirium and frontal-like syndrome with paramedian infarction of the right thalamus. J. Neurol. Neurosurg. Psychiatr.51, 116–119. 10.1136/jnnp.51.1.116
24
BonelliR. M.CummingsJ. L. (2007). Frontal subcortical circuitry and behavior. Dialogues Clin. Neurosci.9, 141–151.
25
BonelliR. M.CummingsJ. L. (2008). Frontal-subcortical dementias. Neurologist14, 100–107. 10.1097/NRL.0b013e31815b0de2
26
BonelliR. M.KapfhammerH. P.PillayS. S.Yurgelun-ToddD. A. (2006). Basal ganglia volumetric studies in affective disorder: what did we learn in the last 15 years?J Neural Transm113, 255–268. 10.1007/s00702-005-0372-7
27
BrodatyH.SachdevP. S.WithallA.AltendorfA.ValenzuelaM. J.LorentzL. (2005). Frequency and clinical: neuropsychological and neuroimaging correlates of apathy following stroke – the Sydney stroke study. Psychol. Med.35, 1707–1716. 10.1017/S0033291705006173
28
BrownL. L. (1992). Somatotopic organization in rat striatum: evidence for a combinational map. Proc. Natl. Acad. Sci. U.S.A.89, 7403–7407. 10.1073/pnas.89.16.7403
29
BrownR. G.PluckG. (2000). Negative symptoms: the “pathology” of motivation and goal-directed behaviour. Trends Neurosci.23, 412–417. 10.1016/S0166-2236(00)01626-X
30
BruenP. D.McGeownW. J.ShanksM. F.VenneriA. (2008). Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain131, 2455–2463. 10.1093/brain/awn151
31
CaeiroL.FerroJ. M.CostaJ. (2013). Apathy secondary to stroke: a systematic review and meta-analysis. Cerebrovasc. Dis.35, 23–39. 10.1159/000346076
32
CaeiroL.FerroJ. M.FigueiraM. L. (2012). Apathy in acute stroke patients. Eur. J. Neurol.19, 291–297. 10.1111/j.1468-1331.2011.03508.x
33
CampbellJ. J.DuffyJ. D. (1997). Treatment strategies in amotivated patients. Psychiatr. Ann.27, 44–49. 10.3928/0048-5713-19970101-11
34
CanevelliM.AdaliN.VoisinT.SotoM. E.BrunoG.CesariM.et al. (2013). Behavioral and psychological subsyndromes in Alzheimer's disease using the Neuropsychiatric Inventory. Int. J. Geriatr. Psychiatry28, 795–803. 10.1002/gps.3904
35
CarreraE.BogousslavskyJ. (2006). The thalamus and behavior: effects of anatomically distinct strokes. Neurology66, 1817–1823. 10.1212/01.wnl.0000219679.95223.4c
36
CastellonS. A.HinkinC. H.WoodS.et al. (1998). Apathy, depression, and cognitive performance in HIV-1 infection. J. Neuro psychiatry Clin. Neurosci.10, 320–329. 10.1176/jnp.10.3.320
37
ChaseT. N. (2011). Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment. Neurotox. Res.19, 266–278. 10.1007/s12640-010-9196-9
38
ChowT. W.BinnsM. A.CummingsJ. L.et al. (2009). Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type. Arch. Neurol.66, 888–893. 10.1001/archneurol.2009.92
39
ChuiH. (2001). Dementia Associated with Subcortical Ischemic Vascular Disease. Dissertation. Philadelphia: American Academy (AAN).
40
ClarkeD. E.KoJ. Y.KuhlE. A.van ReekumR.SalvadorR.MarinR. S. (2011). Are the available apathy measures reliable and valid? A review of the psychometric evidence. J. Psychosom. Res.70, 73–97. 10.1016/j.jpsychores.2010.01.012
41
CombarrosO.InfanteJ.BercianoJ. (2000). Akinetic mutism from frontal lobe damage responding to levodopa. J. Neurol.247, 568–569. 10.1007/s004150070161
42
CraigA. H.CummingsJ. L.FairbanksL.IttiL.MillerB. L.LiJ.et al. (1996). Cerebral blood flow correlates of apathy in Alzheimer disease. Arch. Neurol53, 1116–1120. 10.1001/archneur.1996.00550110056012
43
CritchleyH. D. (2005). Neural mechanisms of autonomic, affective, and cognitive integration. J. Comp. Neurol.493, 154–166. 10.1002/cne.20749
44
CummingsJ.FriedmanJ. H.GaribaldiG.JonesM.MacFaddenW.MarshL.et al. (2015a). Apathy in neurodegenerative diseases: recommendations on the design of clinical trial. J. Geriatr. Psychiatry Neurol.28, 159–173. 10.1177/0891988715573534
45
CummingsJ. L. (2000). Cholinesterase inhibitors: a new class of psychotropic compounds. Am. J. Psychiatry157, 4–15. 10.1176/ajp.157.1.4
46
CummingsJ.MintzerJ.BrodatyH.SanoM.BanerjeeS.DevanandD. P.et al. (2015b). Agitation in cognitive disorders: international psychogeriatric association provisional consensus clinical and research definition. Int. Psychogeriatr.27, 7–17. 10.1017/S1041610214001963
47
CuthbertB. N.InselT. R. (2013). Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med.11:126. 10.1186/1741-7015-11-126
48
DavidR.KoulibalyM.BenoitM.GarciaR.CaciH.DarcourtJ.et al. (2008). Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction. Clin. Neurol. Neurosurg.110, 19–24. 10.1016/j.clineuro.2007.08.007
49
DeguchiK.KonoS.DeguchiS.MorimotoN.KurataT.IkedaY.et al. (2013). A novel useful tool of computerized touch panel-type screening test for evaluating cognitive function of chronic ischemic stroke patients. J. Stroke Cerebrovasc. Dis.22, 197–206. 10.1016/j.jstrokecerebrovasdis.2012.11.011
50
DelrieuJ.DesmidtT.CamusV.SourdetS.Boutoleau-BretonnièreC.MullinE.et al. (2015). Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study. Int. J. Geriatr. Psychiatry30, 470–477. 10.1002/gps.4161
51
DesmurgetM.SiriguA. (2009). A parietal-premotor network for movement intention and motor awareness. Trends Cogn. Sci.13, 411–419. 10.1016/j.tics.2009.08.001
52
Diaz-OlavarrietaC.CummingsJ. L.VelazquezJ.et al. (1999). Neuro-psychiatric manifestations of multiple sclerosis. J. Neuropsychiatry Clin. Neurosci.11, 51–58. 10.1176/jnp.11.1.51
53
DivacI. (1972). Neostriatum and functions of prefrontal cortex. Acta Neurobiol. Exp.32, 461–477.
54
DivacI.RosvoldH. E.SzwarcbartM. K. (1967). Behavioral effects of selective ablation of the caudate nucleus. J. Comp. Physiol. Psychol. 63, 184–190. 10.1037/h0024348
55
DonovanN. J.WadsworthL. P.LoriusN.LocascioJ. J.RentzD. M.JohnsonK. A.et al. (2014). Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum. Am. J. Geriatr. Psychiatry22, 1168–1179. 10.1016/j.jagp.2013.03.006
56
DuffyJ. (2000). Apathy in neurological disorders. Curr. Psychiatry Rep.2, 434–439. 10.1007/s11920-000-0029-z
57
DuffyJ. D. (1997a). Apathy secondary to neurologic disease. Psychiatr. Ann.27, 39–43. 10.3928/0048-5713-19970101-10
58
DuffyJ. D. (1997b). The neural substrates of motivation. Psychiatr. Ann.27, 24–29. 10.3928/0048-5713-19970101-07
59
DujardinK.SockeelP.DelliauxM.DesteeA.DefebvreL. (2009). Apathy may herald cognitive decline and dementia in Parkinsons's disease. Mov. Disord.24, 2391–2397. 10.1002/mds.22843
60
EchiverriH. C.TatumW. O.MerensT. A.CokerS. B. (1988). Akinetic mutism: pharmacologic probe of the dopaminergic mesencephalofrontal activating system. Pediatr. Neurol.4, 228–230. 10.1016/0887-8994(88)90036-7
61
EslingerP. J.DamasioA. R. (1985). Severe disturbance of higher cognition after bilateral frontal lobe ablation: patient EVR. Neurology35, 1731–1741. 10.1212/WNL.35.12.1731
62
FervahaG.FoussiasG.AgidO.RemingtonG. (2015). Motivational deficits in early schizophrenia prevalent, persistent, and key determinants of functional outcome. Schizophr. Res.166, 9–16. 10.1016/j.schres.2015.04.040
63
FieldingJ.Georgiou-KaristianisN.WhiteO. (2006). The role of the basal ganglia in the control of automatic visuospatial attention. J. Int. Neuropsychol. Soc.12, 657–667. 10.1017/S1355617706060784
64
FinsetA.AnderssonS. (2000). Coping strategies in patients with acquired brain injury: relationships between coping, apathy, depression and lesion location. Brain Inj.14, 887–905. 10.1080/026990500445718
65
FlahertyA. W.GraybielA. M. (1993). Output architecture of the primate putamen. J. Neurosci.13, 3222–3237.
66
FusterJ. M. (2001). The prefrontal cortex-an update: time is of the essence. Neuron30, 319–333. 10.1016/S0896-6273(01)00285-9
67
GedaY. E.SchneiderL. S.GitlinL. N.MillerD. S.SmithG. S.BellJ.et al. (2013). Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers. Dement.9, 602–608. 10.1016/j.jalz.2012.12.001
68
GiguereM.Goldman-RakicP. S. (1988). Mediodorsal nucleus: areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys. J. Comp. Neurol.277, 195–213. 10.1002/cne.902770204
69
Goldman-RakicP. S.PorrinoL. J. (1985). The primate mediodorsal (MD) nucleus and its projection to the frontal lobe. J. Comp. Neurol.242, 535–560. 10.1002/cne.902420406
70
GroenewegenH. J.BerendseH. W. (1990). Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat. J. Comp. Neurol.294, 607–622. 10.1002/cne.902940408
71
GrupeD. W.NitschkeJ. B. (2013). Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nat. Rev. Neurosci.14, 488–501. 10.1038/nrn3524
72
GuercioB. J.DonovanN. J.WardA.SchultzA.LoriusN.AmariglioR. E.et al. (2015). Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals. J. Neuropsychiatry Clin. Neurosci.27, 22–27. 10.1176/appi.neuropsych.13060141
73
GuimaraesH. C.LevyR.TeixeiraA. L.BeatoR. G.CaramelliP. (2008). Neurobiology of apathy in Alzheimer's disease. Arq. Neuropsiquiatry66, 436–443. 10.1590/S0004-282X2008000300035
74
HahnC.LimH. K.WonW. Y.AhnK. J.JungW. S.LeeC. U. (2013). Apathy and white matter integrity in Alzheimer's disease: a whole brain analysis with tract-based spatial statistics. PLoS ONE8:e53493. 10.1371/journal.pone.0053493
75
HamaS.YamashitaH.ShigenobuM.WatanabeA.KurisuK.YamawakiS.et al. (2007). Post-stroke affective or apathetic depression and lesion location: left frontal lobe and bilateral basal ganglia. Eur. Arch. Psychiatry Clin. Neurosci.257, 149–152. 10.1007/s00406-006-0698-7
76
HelgasonC.WilburA.WeissA.RedmondK. J.KingsburyN. A. (1988). Acute pseudobulbar mutism due to discrete bilateral capsular infarction in the territory of the anterior choroidal artery. Brain111, 507–524. 10.1093/brain/111.3.507
77
HirataK.TanakaH.ZengX. H.HozumiA.AraiM. (2006). The role of the basal ganglia and cerebellum in cognitive impairment: a study using eventrelated potentials. Suppl. Clin. Neurophysiol.59, 49–55. 10.1016/S1567-424X(09)70011-X
78
Hoehn-SaricR.LipseyJ. R.McLeodD. R. (1990). Apathy and indifference in patients on fluvoxamine and fluoxetine. J. Clin. Psychopharmacol.10, 343–346. 10.1097/00004714-199010000-00007
79
HoffmannM.CasesL. B. (2008). Etiology of frontal network syndromes in isolated subtentorial stroke. Behav. Neurol.20, 101–105. 10.1155/2008/635187
80
HoffstaedterF.GrefkesC.ZillesK.EickhoffS. B. (2013). The what and when of self-initiated movements. Cereb. Cortex23, 520–530. 10.1093/cercor/bhr391
81
HolthoffV. A.Beuthien-BaumannB.KalbeE.LüdeckeS.LenzO.ZündorfG.et al. (2005). Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biol. Psychiatry57, 412–421. 10.1016/j.biopsych.2004.11.035
82
HuangC.RavdinL. D.NirenbergM. J.PiboolnurakP.SevertL.ManiscalcoJ. S.et al. (2013). Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study. Dement. Geriatr. Cogn. Disord.35, 183–196. 10.1159/000345987
83
IllinskyI. A.JouandetM. L.Goldman-RakicP. S. (1985). Organization of the nigrothalamocortical system in the rhesus monkey. J. Comp. Neurol.236, 315–330. 10.1002/cne.902360304
84
InselT.CuthbertB.GarveyM.HeinssenR.PineD. S.QuinnK.et al. (2010). Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry167, 748–751. 10.1176/appi.ajp.2010.09091379
85
IsellaV.MelziP.GrimaldiM.IurlaroS.PioltiR.FerrareseC.et al. (2002). Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease. Mov. Disord.17, 366–371. 10.1002/mds.10041
86
IshiiS.WeintraubN.MervisJ. R. (2009). Apathy: a common psychiatric syndrome in the elderly. J. Am. Med. Dir. Assoc.10, 381–393. 10.1016/j.jamda.2009.03.007
87
JackC. R.KnopmanD. S.JagustW. J.PetersenR. C.WeinerM. W.AisenP. S.et al. (2013). Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol.12, 207–216. 10.1016/S1474-4422(12)70291-0
88
JellingerK. A. (2013). Pathology and pathogenesis of vascular cognitive-impairment-a critical update. Fronit. Aging Neurosci.5:17. 10.3389/fnagi.2013.00017
89
JenkinsI. H.JahanshahiM.JueptnerM.PassinghamR. E.BrooksD. J. (2000). Self-initiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow. Brain123, 1216–1228. 10.1093/brain/123.6.1216
90
JesteD. V.FinkelS. I. (2000). Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am. J. Geriatr. Psychiatry8, 29–34. 10.1097/00019442-200002000-00004
91
JohnsonT. N.RosvoldH. E. (1971). Topographic projections on the globus pallidus and the substantia nigra of selectively placed lesions in the precommissural caudate nucleus and putamen in the monkey. Exp. Neurol.33, 584–596. 10.1016/0014-4886(71)90129-4
92
JohnsonT. N.RosvoldH. E.MishkinM. (1968). Projections from behaviorally defined sectors of the prefrontal cortex to the basal ganglia, septum, and diencephalon of the monkey. Exp. Neurol.21, 20–34. 10.1016/0014-4886(68)90030-7
93
JonssonM.EdmanA.LindK.RolstadS.SjogrenM.WallinA. (2010). Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia. Int. J. Geriatr. Psychiatry25, 588–595. 10.1002/gps.2379
94
JorgeR. E.StarksteinS. E.RobinsonR. G. (2010). Apathy following stroke. Can. J. Psychiatry55, 350–354. 10.1177/070674371005500603
95
HsiehC. J.ChuH.ChengJ. J.ShenW. W.LinC. C. (2012). Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer's disease. Psychiatry Clin. Neurosci.66, 227–234. 10.1111/j.1440-1819.2011.02315.x
96
Jurado-ParrasM. T.GruartA.Delgado-GarcíaJ. M. (2012). Observational learning in mice can be prevented by medial prefrontal cortex stimulation and enhanced by nucleus accumbens stimulation. Learn. Mem.19, 99–106. 10.1101/lm.024760.111
97
KalivasP. W.ChurchillL.KliteneckM. A. (1994). The circuitry mediating the translation of motivational stimuli into adaptive motor responses, in Limbic Motor Circuits and Neuropsychiatry, eds KalivasP. W.BarnesC. D. (Boca Raton, FL: CRC Press), 237–287.
98
KangJ. Y.LeeJ. S.KangH.LeeH. W.KimY. K.JeonH. J.et al. (2012). Regional cerebral blood flow abnormalities associated with apathy and depression in Alzheimer disease. Alzheimer Dis. Assoc. Disord.26, 217–224. 10.1097/WAD.0b013e318231e5fc
99
KantR.DuffyJ. D.PivovarnikA. (1998). Apathy following closed head injury. Brain Inj.12, 87–92. 10.1080/026990598122908
100
KievitJ.KuypersH. G. (1977). Organization of the thalamo-cortical connexions to the frontal lobe in the rhesus monkey. Exp. Brain Res.29, 299–322. 10.1007/bf00236173
101
KimJ. W.LeeD. Y.ChooI. H.SeoE. H.KimS. G.ParkS. Y.et al. (2011). Microstructural alteration of the anterior cingulum is associated with apathy in Alzheimer disease. Am. J. Geriatr. Psychiatry19, 644–653. 10.1097/JGP.0b013e31820dcc73
102
KimR.NakanoK.JayaramanA.CarpenterM. B. (1976). Projections of the globus pallidus and adjacent structures: an autoradiographic study in the monkey. J. Comp. Neurol.169, 263–290. 10.1002/cne.901690302
103
KolbB.PellisS.RobinsonT. E. (2004). Plasticity and functions of the orbital frontal cortex. Brain Cogn.55, 104–115. 10.1016/S0278-2626(03)00278-1
104
KosC.van TolM. J.MarsmanJ. B.KnegteringH.AlemanA. (2016). Neural correlates of apathy in patients with neurodegenerative disorders, acquired brain injury, and psychiatric disorders. Neurosci. Biobehav. Rev.69, 381–401. 10.1016/j.neubiorev.2016.08.012
105
KosticV. S.FilippiM. (2011). Neuroanatomical correlates of depression and apathy in Parkinson's disease: magnetic resonance imaging studies. J. Neurol. Sci.310, 61–63. 10.1016/j.jns.2011.05.036
106
Kronforst-CollinsM. A.DisterhoftJ. F. (1998). Lesions of the caudal area of rabbit medial prefrontal cortex impair trace eyeblink conditioning. Neurobiol. Learn. Mem.69, 147–162. 10.1006/nlme.1997.3818
107
LanctôtK. L.MoosaS.HerrmannN.LeibovitchF. S.RothenburgL.CotterA.et al. (2007). A SPECT study of apathy in Alzheimer's disease. Dement. Geriatr. Cogn. Disord.24, 65–72. 10.1159/000103633
108
LatteryM.GarveyM.SwedoS. (2001). Frontal-subcortical circuits: a functional developmental approach, in Frontal Subcortical Circuits in Psychiatric and Neurological Disorders, eds LichterD. G.CummingsJ. L. (New York, NY: Guilford Press), 314–33.
109
Leal-CampanarioR.Delgado-GarciaJ. M.GruartA. (2013). The rostral medial prefrontal cortex regulates the expression of conditioned eyelid responses in behaving rabbits. J. Neurosci.33, 4378–4386. 10.1523/JNEUROSCI.5560-12.2013
110
Leal-CampanarioR.FairénA.Delgado-GarcíaJ. M.GruartA. (2007). Electrical stimulation of the rostral medial prefrontal cortex in rabbits inhibits the expression of conditioned eyelid responses but not their acquisition. Proc. Natl. Acad. Sci. U.S. A.104, 11459–11464. 10.1073/pnas.0704548104
111
LehericyS.BardinetE.TremblayL.et al. (2006). Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cereb. Cortex16, 149–161. 10.1093/cercor/bhi089
112
LevyM. L.CummingsJ. L.FairbanksL. A.et al. (1998). Apathy is not depression. J. Neuropsychiatry Clin. Neurosci.10, 314–319. 10.1176/jnp.10.3.314
113
LevyR.DuboisB. (2006). Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb. Cortex16, 916–928. 10.1093/cercor/bhj043
114
LichterD. G.CummingsJ. L. (2001). Introduction and overview, in Frontal-Subcortical Circuits in Psychiatric and Neurological Disorders eds LichterD. G.CummingsJ. L. (New York, NY: Guilford Press), 1–43.
115
LitvanI. (2001). Personality and behavioral changes with frontal-subcortical dysfunction, in Frontal-Subcortical Circuits in Psychiatric and Neurological Disorders, eds LichterD. G.CummingsJ. L. (New York, NY: Guilford Press), 151–62.
116
LitvanI.CummingsJ. L.MegaM. (1998). Neuropsychiatric features of corticobasal degeneration. J. Neurol. Neurosurg. Psychiatr.65, 717–721. 10.1136/jnnp.65.5.717
117
LjungbergT.UngerstedtU. (1976). Reinstatement of eating by dopamine agonists in aphagic dopamine denervated rats. Physiol. Behav.16, 277–283. 10.1016/0031-9384(76)90133-5
118
LoewensteinD. A.ArguellesS.BravoM.et al. (2001). Caregivers judgments of the functional abilities of the Alzheimer's disease patient: a comparison of proxy reports and objective measures. J. Gerontol. B Psychol. Sci. Soc. Sci.56, 78–84. 10.1093/geronb/56.2.p78
119
LyketsosC. G.LopezO.JonesB.FitzpatrickA. L.BreitnerJ.DeKoskyS. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA288, 1475–1483. 10.1001/jama.288.12.1475
120
LyketsosC. G.SteinbergM.TschanzJ. T.NortonM. C.SteffensD. C.BreitnerJ. C. (2000). Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am. J. Psychiatry157, 708–714. 10.1176/appi.ajp.157.5.708
121
MarinR. S. (1996). Apathy: concept, syndrome, neural mechanisms, and treatment. Semin. Clin. Neuropsychiatry1, 304–314.
122
MarinR. S. (1997a). Differential diagnosis of apathy and related disorders of diminished motivation. Psychiatr. Ann.27, 30–33. 10.3928/0048-5713-19970101-08
123
MarinR. S. (1997b). Apathy-who cares? An introduction to apathy and related disorders of motivation. Psychiatr. Ann.27, 23. 10.3928/0048-5713-19970101-06
124
MarinR. S.BiedrzyckiR. C.FirinciogullariS. (1991). Reliability and validity of the apathy evaluation scale. Psychiatr. Res.38, 143–162. 10.1016/0165-1781(91)90040-V
125
MarinR. S.FogelB. S.HawkinsJ.DuffyJ.KruppB. (1995). Apathy: a treatable syndrome. J. Neuropsychiatry Clin. Neurosci.7, 23–30. 10.1176/jnp.7.1.23
126
MarshallG. A.DonovanN. J.LoriusN.GidicsinC. M.MayeJ.PepinL. C.et al. (2013). Apathy is associated with increased amyloid burden in mild cognitive impairment. J. Neuropsychiatry Clin. Neurosci.25, 302–307. 10.1176/appi.neuropsych.12060156
127
MarshallJ. F.GotthelfT. (1979). Sensory inattention in rats with 6- hydroxydopamine- induced degeneration of ascending dopaminergic neurons: apomorphine- induced reversal of deficits. Exp. Neurol.65, 398–411. 10.1016/0014-4886(79)90107-9
128
MarshallJ. F.UngerstedtU. (1976). Apomorphine-induced restoration of drinking to thirst challenges in 6-hydroxydopamine-treated rats. Physiol. Behav.17, 817–822. 10.1016/0031-9384(76)90047-0
129
MassimoL.PowersC.MooreP.et al. (2009). Neuroanatomy of apathy and disinhibition in frontotemporal lobar degeneration. Dement. Geriatr. Cogn. Disord.27, 96–104. 10.3389/fnhum.2015.00611
130
MatsuokaK.YasunoF.TaguchiA.YamamotoA.KajimotoK.KazuiH.et al. (2015). Delayed atrophy in posterior cingulate cortex and apathy after stroke. Int. J. Geriatr. Psychiatry30, 566–572. 10.1002/gps.4185
131
McConnellH.SnyderP.DuffyJ. D. (1996). Behavioral effects of felbamate. J. Neuropsychiatry Clin. Neurosci.8, 341–347
132
McIntoshR. C.RosselliM.UddinL. Q.AntoniM. (2015). Neuropathological sequelae of human immunodefciency virus and apathy: a review of neuropsychological and neuroimaging studies. Neurosci. Biobehav. Rev.55, 147–164. 10.1016/j.neubiorev.2015.04.008
133
MegaM. S.CohenourR. C. (1997). Akinetic mutism: disconnection of frontal- subcortical circuits. Neuropsychiatry Neuropsychol. Behav. Neurol.10, 254–259.
134
MegaM. S.CummingsJ. L.SallowayS.MalloyP. (1997). The limbic system: an anatomic, phylogenetic, and clinical perspective. J. Neuropsychiatry Clin. Neurosci.9, 315–330. 10.1176/jnp.9.3.315
135
MegaM. S.DinovI. D.PorterV.ChowG.RebackE.DavoodiP.et al. (2005). Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study. Arch. Neurol.62, 721–728. 10.1001/archneur.62.5.721
136
MignecoO.BenoitM.KoulibalyP. M.DygaiI.BertogliatiC.DesvignesP.et al. (2001). Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: a study in Alzheimer's disease and nondemented patients. Neuroimage13, 896–902. 10.1006/nimg.2000.0741
137
MollJ.ZahnR.de Oliveira-SouzaR.et al. (2011). Impairment of prosocial sentiments is associated with frontopolar and septal damage in frontotemporal dementia. Neuroimage54, 1735–1742. 10.1016/j.neuroimage.2010.08.026
138
MonchiO.PetridesM.StrafellaA. P.WorsleyK. J.DoyonJ. (2006). Functional role of the basal ganglia in the planning and execution of actions. Ann. Neurol.59, 257–264. 10.1002/ana.20742
139
MoonY.KimH.KimJ.HanS. H. (2014a). Vascular factors are associated with the severity of the neuropsychiatric symptoms in Alzheimer's disease. Int. J. Neurosci.124, 512–517. 10.3109/00207454.2013.856902
140
MoonY.MoonW. J.KimH.HanS. H. (2014b). Regional atrophy of the insular cortex is associated with neuropsychiatric symptoms in Alzheimer's disease patients. Eur. Neurol.71, 223–229. 10.1159/000356343
141
MorettiR.CavressiM.TomiettoP. (2015). Gait and apathy as a relevant symptom of Subcortical vascular dementia. Am. J. Alzheimers Dis. Other. Demen.30, 390–399. 10.1177/1533317514550329
142
MorettiR.TorreP.AntonelloR. M.CazzatoG. (2005). Corticobasal Ganglionic Degeneration. New York, NY: Nova Publisher.
143
MorettiR.TorreP.AntonelloR. M.Vidus RosinM.EspositoF.Rubelli FurmanM.et al. (2012). Apathy: a complex symptom, specific to the clinical pattern pf presentation of Parkinson's Disease. Am. J. Alzheimer's Disease Other Demen.27, 196–201. 10.1177/1533317512445502
144
MorettiR.TorreP.EspositoF.BarroE.TomiettoP.AntonelloR. M. (2013). Apathy as a key symptom in behavior disorders: difference between Alzheimer's disease and subcortical vascular dementia, in Understanding Alzheimer's Disease, ed ZerrI. (Rijeka, Croatia: InTech Europe), Chapter 14.
145
MoriT.ShimadaH.ShinotohH.HiranoS.EguchiY.YamadaM.et al. (2014). Apathy correlates with prefrontal amyloid β deposition in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatr.85, 449–455. 10.1136/jnnp-2013-306110
146
NácherV.OjedaS.Cadarso-SuárezC.Roca-Pardi-asJ.Acu-aC. (2006). Neural correlates of memory retrieval in the prefrontal cortex. Eur. J. Neurosci.24, 925–936. 10.1111/j.1460-9568.2006.04964.x
147
NemethG.HegedusK.MolnarL. (1986). Akinetic mutism and locked- in syndrome: the functional-anatomical basis for their differentiation. Fund. Neurol.1, 128–139.
148
NjomboroP.DebS. (2012). Poor dissociation of patient-evaluated apathy and depressive symptoms. Curr. Gerontol. Geriatr. Res.2012:846075. 10.1155/2012/846075
149
OberndorferS.UrbanitsS.LahrmannH.KirschnerH.KumpanW.GrisoldW. (2002). Akinetic mutism caused by bilateral infiltration of the fornix in a patient with astrocytoma. Eur. J. Neurol.9, 311–313. 10.1046/j.1468-1331.2002.00386.x
150
OkadaK.KobayashiS.YamagataS.et al. (1997). Poststroke apathy and regional cerebral blood flow. Stroke28, 2437–2441. 10.1161/01.STR.28.12.2437
151
OkadaS.YamanouchiN.KodamaK.et al. (1999). Regional cerebral blood flow abnormalities in chronic solvent abusers. Psychiatry Clin. Neurosci.53, 351–356. 10.1046/j.1440-1819.1999.00557.x
152
OlinJ. T.SchneiderL. S.KatzI. R.MeyersB. S.AlexopoulosG. S.BreitnerJ. C.et al. (2002). Provisional diagnostic criteria for depression of Alzheimer disease. Am. J. Geriatr. Psychiatry10, 125– 128. 10.1097/00019442-200203000-00003
153
OnodaK.KurodaY.YamamotoY.AbeS.OguroH.NagaiA.et al. (2011). Post-stroke apathy and hypoperfusion in basal ganglia: SPECT study. Cerebrovasc. Dis.31, 6–11. 10.1159/000319771
154
OnodaK.YamaguchiS. (2011). Dissociative contributions of the anterior cingulate cortex to apathy and depression: topological evidence from resting-state functional MRI. Neuropsychologia77, 10–18. 10.1016/j.neuropsychologia.2015.07.030
155
OommanA.MadhusudhananM. (1999). A case of unpaired anterior cerebral artery occlusion producing akinetic mutism. Neurol. India47, 157–158.
156
OtaM.SatoN.NakataY.ArimaK.UnoM. (2012). Relationship between apathy and diffusion tensor imaging metrics of the brain in Alzheimer's disease. Int. J. Geriatr. Psychiatry27, 722–726. 10.1002/gps.2779
157
OttB. R.LaflecheG.WhelihanW. M.et al. (1996). Impaired awareness of deficits in Alzheimer's Disease. Alzheimer Dis. Assoc. Disord.10, 68–76. 10.1097/00002093-199601020-00003
158
PalmqvistS.SarwariA.WattmoC.et al. (2011). Association between subcortical lesions and behavioral and psychological symptoms in patients with Alzheimer's disease. Dement Geriatr. Cogn. Diord.32, 417–423. 10.1159/000335778
159
ParentA. (1990). Extrinsic connections of the basal ganglia. Trends Neurosci.13, 254–258. 10.1016/0166-2236(90)90105-J
160
ParentA.BouchardC.SmithY. (1984). The striatopallidal and striatonigral projections: two distinct fiber systems in primate. Brain Res.303, 385–390. 10.1016/0006-8993(84)91224-1
161
PetersF.PeraniD.HerholzK.et al. (2006). Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement. Geriatr. Cogn. Disord.21, 373–379. 10.1159/000091898
162
PetersM. E.SchwartzS.HanD.RabinsP. V.SteinbergM.TschanzJ. T.et al. (2015). Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County dementia progression study. Am. J. Psychiatry172, 460–465. 10.1176/appi.ajp
163
PetrosiniL. (2007). “Do what I do” and “Do how I do”: different components of imitative learning are mediated by different neural structures. Neuroscientist13, 335–348. 10.1177/10738584070130040701
164
PiamartaF.IurlaroS.IsellaV.AtzeniL.GrimaldiM.RussoA.et al. (2004). Unconventional affective symptoms and executive functions after stroke in the elderly. Arch. Gerontol. Geriatr.9, 315–323. 10.1016/j.archger.2004.04.042
165
PluckG. C.BrownR. G. (2002). Apathy in Parkinson's disease. J. Neurol. Neurosurg. Psychiatr.73, 636–642. 10.1136/jnnp.73.6.636
166
PorsteinssonA. P.DryeL. T.PollockB. G.DevanandD. P.FrangakisC.IsmailZ.et al. (2014). Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA311, 682–691. 10.1001/jama.2014.93
167
PostumaR. B.DagherA. (2006). Basal ganglia functional connectivity based on a meta-analysis of 126 positron emission tomography and functional magnetic resonance imaging publications. Cereb. Cortex16, 1508–1521. 10.1093/cercor/bhj088
168
QuarantaD.MarraC.RossiC.GainottiG.MasulloC. (2012). Different apathy profile in behavioral variant of frontotemporal dementia and alzheimer's disease: a preliminary investigation. Curr. Gerontol. Geriatrics Res.2012:719250. 10.1155/2012/719250
169
ReevesS.BrownR.HowardR.GrasbyP. (2009). Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease. Neurology72, 528–534. 10.1212/01.wnl.0000341932.21961.f3
170
ReijndersJ. S.ScholtissenB.WeberW. E.AaltenP.VerheyF. R.LeentjensA. F. (2010). Neuroanatomical correlates of apathy in Parkinson's disease: a magnetic resonance imaging study using voxel-based morphometry. Mov. Disord.25, 2318–2325. 10.1002/mds.23268
171
RemyP.DoderM.LeesA.TurjanskiN.BrooksD. (2005). Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain128, 1314–1322. 10.1093/brain/awh445
172
RobertG.Le JeuneF.DondaineT.DrapierS.PeronJ.LozachmeurC.et al. (2014). Apathy and impaired emotional facial recognition networks overlap in Parkinson's disease: a PET study with conjunction analyses. J. Neurol. Neurosurg. Psychiatr.85, 1153–1158. 10.1136/jnnp-2013-307025
173
RobertG.Le JeuneF.LozachmeurC.DrapierS.DondaineT.PeronJ.et al. (2012). Apathy in patients with Parkinson disease without dementia or depression: a PET study. Neurology79, 1155–1160. 10.1212/WNL.0b013e3182698c75
174
RobertP. H.DarcourtG.KoulibalyM. P.ClairetS.BenoitM.GarciaR.et al. (2006). Lack of initiative and interest in Alzheimer's disease: a single photon emission computed tomography study. Eur. J. Neurol.13, 729–735. 10.1111/j.1468-1331.2006.01088.x
175
RobertP.OnyikeC. U.LeentjensA. F.DujardinK.AaltenP.StarksteinS.et al. (2009). Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur. Psychiatry24, 98–104. 10.1016/j.eurpsy.2008.09.001
176
RochatL.Van der LindenM.RenaudO.EpineyJ. B.MichelP.SztajzelR.et al. (2013). Poor reward sensitivity and apathy after stroke: implication of basal ganglia. Neurology81, 1674–1680. 10.1212/01.wnl.0000435290.49598.1d
177
RomanG. C.TatemichiT. K.ErkinjunttiT.et al. (1993). Vascular dementia: diagnostic criteria for research studies. Report of the NINDS- AIREN international work group. Neurology43, 250–260. 10.1212/WNL.43.2.250
178
RosenH. J.AllisonS. C.SchauerG. F.Gorno-TempiniM. L.WeinerM. W.MillerB. L. (2005). Neuroanatomical correlates of behavioral disorders in dementia. Brain128, 2612–2625. 10.1093/brain/awh628
179
RosenbergP. B.LanctôtK. L.DryeL. T.HerrmannN.SchererR. W.BachmanD. L.et al. (2013). Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. J. Clin. Psychiatry74, 810–816. 10.4088/JCP.12m08099
180
RossE. D.StewartR. M. (1981). Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists. Neurology31, 1435–1439. 10.1212/WNL.31.11.1435
181
SalmonD.HeindelW. C.HamiltonJ. M. (2001). Cognitive abilities mediated by frontal-subcortical circuits, in Frontal Subcortical Circuits in Psychiatric and Neurological Disorders, eds LichterD. G.CummingsJ. L. (New York, NY: Guilford Press), 114–150.
182
SantangeloG.TrojanoL.BaroneP.ErricoD.GrossiD.VitaleC. (2013). Apathy in Parkinson's disease: diagnosis, neuropsychological correlates, pathophysiology and treatment. Behav. Neurol.27, 501–513. 10.1155/2013/851890
183
SchroeterM. L.VogtB.FrischS.BeckerG.SeeseA.BarthelH.et al. (2011). Dissociating behavioral disorders in early dementia-an FDG-PET study. Psychiatry Res.194, 235–244. 10.1016/j.pscychresns.2011.06.009
184
SelemonL. D.Goldman-RakicP. S. (1985). Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J. Neurosci.5, 776–794.
185
SiegelJ. J.KalmbachB.ChitwoodR. A.MaukM. D. (2012). Persistent activity in a cortical-to-subcortical circuit: bridging the temporal gap in trace eyelid conditioning. J. Neurophysiol.107, 50–64. 10.1152/jn.00689.2011
186
SimonB.KnuckleyB.ChurchwellJ. (2005). Powell DAPost-training lesions of the medial prefrontal cortex interfere with subsequent performance of trace eyeblink conditioning. J. Neurosci.25, 10740–10746. 10.1523/JNEUROSCI.3003-05.2005
187
SkidmoreF. M.YangM.BaxterL.von DeneenK.CollingwoodJ.HeG.et al. (2013). Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson disease. Neuroimage81, 484–495. 10.1016/j.neuroimage.2011.07.012
188
SkogsethR.MulugetaE.JonesE.BallardC.RongveA.NoreS.et al. (2008). Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease. Dement. Geriatr. Cogn. Disord.25, 559–563. 10.1159/000137671
189
SmithA. D.BolamJ. P. (1990). The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci.13, 259–265. 10.1016/0166-2236(90)90106-K
190
SmithY.HazratiL. N.ParentA. (1990). Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method. J. Comp. Neurol.294, 306–323. 10.1002/cne.902940213
191
StantonB. R.LeighP. N.HowardR. J.BarkerG. J.BrownR. G. (2013). Behavioral and emotional symptoms of apathy are associated with distinct patterns of brain atrophy in neurodegenerative disorders. J. Neurol.260, 2481–2490. 10.1007/s00415-013-6989-9
192
StarksteinS. E.FedoroffJ. P.PriceT. R.LeïguardaR.RobinsonR. G. (1993). Apathy following cerebrovascular lesions. Stroke24, 1625–1630. 10.1161/01.STR.24.11.1625
193
StarksteinS. E.KremerJ. (2001). The disinhibition syndrome and frontal-subcortical circuits, in Frontal Subcortical Circuits in Psychiatric and Neurological Disorders, eds LichterD. G.CummingsJ. L. (New York, NY: Guilford Press) 163–76.
194
StarksteinS. E.LeentjensA. F. (2008). The nosological position of apathy in clinical practice. J. Neurol. Neurosurg. Psychiatry10, 202–209. 10.1136/jnnp.2007.136895
195
StarksteinS. E.MaybergS. E.PreziosiT. J.et al. (1992). Reliability, validity and clinical correlates of apathy in Parkinson's disease. J. Neuropsychiatry4, 134–139. 10.1176/jnp.4.2.134
196
StarksteinS. E.MizrahiR.CapizzanoA. A.et al. (2009). Neuroimaging correlates of apathy and depression in Alzheimer's Disease. J. Neuropsychiatry Clin. Neurosci.21, 259–265. 10.1176/jnp.2009.21.3.259
197
StarksteinS. E.SabeL.VazquezS.Di LorenzoG.MartinezA.PetraccaG.et al. (1997). Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatr.63, 66–73. 10.1136/jnnp.63.1.66
198
SteinbergM.ShaoH.ZandiP.LyketsosC. G.Welsh-BohmerK. A.NortonM. C.et al. (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int. J. Geriatr. Psychiatry23, 170–177. 10.1002/gps.1858
199
StellaF.RadanovicM.AprahamianI.CanineuP. R.de AndradeL. P.ForlenzaO. V. (2014). Neurobiological correlates of apathy in Alzheimer's disease and mild cognitive impairment: a critical review. J. Alzheimers. Dis.39, 633–648. 10.3233/JAD-131385
200
StussD. T.Van ReekumR.MurphyK. J. (2000). Differentiation of states and causes of apathy, in The Neuropsychology of Emotion, ed BorodJ. C. (Oxford: Oxford University Press), 340.
201
SultzerD. L.DavisS. M.TariotP. N.DagermanK. S.LebowitzB. D.LyketsosC. G.et al. (2008). Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am. J. Psychiatry165, 844–854. 10.1176/appi.ajp.2008.07111779
202
TangW. K.ChenY. K.LiangH. J.ChuW. C.MokV. C.UngvariG. S.et al. (2013). Location of infarcts and apathy in ischemic stroke. Cerebrovasc. Dis.35, 566–571. 10.1159/000351152
203
TatemichiT. K.DesmondD. W.ProhovnikI.et al. (1992). Confusion and memory loss from capsular genu infarction. Neurology42, 1966–1979. 10.1212/WNL.42.10.1966
204
TekinS.CummingsJ. L. (2002). Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J. Psychosom. Res.53, 647–654. 10.1016/S0022-3999(02)00428-2
205
TengvarC.JohanssonB.SorensenJ. (2004). Frontal lobe and cingulate cortical metabolic dysfunction in acquired akinetic mutism: a PET study of the interval form of carbon monoxide poisoning. Brain Inj.18, 615–625. 10.1080/02699050310001622806
206
TheleritisC.PolitisA.SiarkosK.LyketsosC. G. (2014). A review of neuroimaging findings of apathy in Alzheimer's disease. Int. Psychogeriatr.26, 195–207. 10.1017/s1041610213001725
207
TigheS. K.OishiK.MoriS.SmithG. S.AlbertM.LyketsosC. G.et al. (2012). Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia. J. Neuropsychiatry Clin.24, 484–488. 10.1176/appi.neuropsych.11120375
208
TrzepaczP. T.YuP.BhamidipatiP. K.WillisB.ForresterT.TabasL.et al. (2013). Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease. Alzheimer Dement9, 95–104. 10.1016/j.jalz.2012.10.005
209
TunnardC.WhiteheadD.HurtC.WahlundL. O.MecocciP.TsolakiM.et al. (2011). Apathy and cortical atrophy in Alzheimer's disease. Int. J. Geriatr. Psychiatry26, 741–748. 10.1002/gps.2603
210
UngerstedtU. (1970). Is interruption of the nigro-striatal dopamine system producing the “lateral hypothalamus syndrome”?Acta Physiol. Scand.80, 35–36. 10.1111/j.1748-1716.1970.tb04858.x
211
UngerstedtU. (1971). Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro- striatal dopamine system. Acta Physiol. Scand. Suppl.367, 95–122. 10.1111/j.1365-201X.1971.tb11001.x
212
van DalenJ. W.van CharanteE. P.NederkoornP. J.van GoolW. A.RichardE. (2013). Poststroke apathy. Stroke44, 851–860. 10.1161/STROKEAHA.112.674614
213
van ReekumR.StussD. T.OstranderL. (2005). Apathy: why care?J. Neuropsychiatry Clin. Neurosci.17, 7–19. 10.1176/jnp.17.1.7
214
WatanabeM. D.MartinE. M.DeLeonO. A.GaviriaM.PavelD. G.TrepashkoD. W. (1995). Successful methylphenidate treatment of apathy after subcortical infarcts. J. Neuropsychiatry Clin. Neurosci.7, 502–504. 10.1176/jnp.7.4.502
215
WeinbergerD. R. (1993). A connectionist approach to the prefrontal cortex. J. Neuropsychiatry Clin. Neurosci.5, 241–253. 10.1176/jnp.5.3.241
216
WeissC.DisterhoftJ. F. (2011). Exploring prefrontal cortical memory mechanisms with eyeblink conditioning. Behav. Neurosci.125, 318–326. 10.1037/a0023520
217
WesterholzJ.SchackT.KoesterD. (2014). The what-decision in manual action: ERPs for free choice versus specified overt goal-related grasping. Neurosci. Lett.575, 85–90. 10.1016/j.neulet.2014.05.022
218
YangS. R.ShangX. Y.TaoJ.LiuJ. Y.HuaP. (2015). Voxel-based analysis of fractional anisotropy in post-stroke apathy. PLoS ONE10:e116168. 10.1371/journal.pone.0116168
219
YeterianE. H.PandyaD. N. (1991). Prefrontostriatal connections in relation to cortical architectonic organization in rhesus monkeys. J. Comp. Neurol.312, 43–67. 10.1002/cne.903120105
220
YeterianE. H.Van HoesenG. W. (1978). Cortico-striate projections in the rhesus monkey: the organization of certain cortico-caudate connections. Brain Res.139, 43–63. 10.1016/0006-8993(78)90059-8
221
ZamboniG.HueyE. D.KruegerF.NichelliP. F.GrafmanJ. (2008). Apathy and disinhibition in frontotemporal dementia: insights into their neural correlates. Neurology71, 36–742. 10.1212/01.wnl.0000324920.96835.95
222
ZhaoH.TangW.XuX.ZhaoZ.HuangL. (2014). Functional magnetic resonance imaging study of apathy in Alzheimer's disease. J. Neuropsychiatry Clin. Neurosci. [Epub ahead of print]. 10.1176/appi.neuropsych.12110261
Summary
Keywords
apathy, frontal cortex, striatum, parietal lobe, nucleus accumbens, anterior cingulate cortex
Citation
Moretti R and Signori R (2016) Neural Correlates for Apathy: Frontal-Prefrontal and Parietal Cortical- Subcortical Circuits. Front. Aging Neurosci. 8:289. doi: 10.3389/fnagi.2016.00289
Received
22 October 2016
Accepted
15 November 2016
Published
09 December 2016
Volume
8 - 2016
Edited by
Lia Fernandes, University of Porto, Portugal
Reviewed by
José M. Delgado-García, Pablo de Olavide University, Spain; Alessandro Martorana, University of Rome Tor Vergata, Italy
Updates
Copyright
© 2016 Moretti and Signori.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Rita Moretti moretti@units.it
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.